0000000000454772

AUTHOR

Gary Barrios

showing 1 related works from this author

Administration of triclabendazole is safe and effective in controlling fascioliasis in an endemic community of the Bolivian Altiplano.

2012

Background The Bolivian northern Altiplano is characterized by a high prevalence of Fasciola hepatica infection. In order to assess the feasibility, safety and efficacy of large-scale administration of triclabendazole as an appropriate public health measure to control morbidity associated with fascioliasis, a pilot intervention was implemented in 2008. Materials and Methods Schoolchildren from an endemic community were screened for fascioliasis and treated with a single administration of triclabendazole (10 mg/kg). Interviews to assess the occurrence of adverse events were conducted on treatment day, one week later, and one month after treatment. Further parasitological screenings were perf…

MaleVeterinary medicineEndemic DiseasesNon-Clinical Medicinemedicine.medical_treatmentRC955-962Arctic medicine. Tropical medicineMedicineChildAnthelminticsbiologyTreatment OutcomeInfectious DiseasesTriclabendazoleChild PreschoolMedicineFemalePublic HealthPublic aspects of medicineRA1-1270After treatmentResearch Articlemedicine.drugSingle administrationBoliviaFascioliasismedicine.medical_specialtyAdolescentDrug-Related Side Effects and Adverse ReactionsChemopreventionInterviews as TopicInternal medicineparasitic diseasesAnimalsHumansFasciola hepaticaAdverse effectTriclabendazoleTreatment GuidelinesChemotherapyHealth Care Policybusiness.industryPublic healthPublic Health Environmental and Occupational HealthDrug PolicyFasciola hepaticabiology.organism_classificationParasitologyBenzimidazolesPreventive MedicinebusinessPLoS Neglected Tropical Diseases
researchProduct